Jul.15.2022
Management / Finance
Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock-based Remuneration
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director & CEO, Gyo Sagara) announced that disposal of treasury shares was completed today, as announced in the press release “Announcement on Disposal of Treasury Shares as Restricted Stock-based Remuneration” on June 23, 2022. The result of treasury shares is as follows:
Overview of Disposal of Treasury Shares
| （１）Disposal date | July 15, 2022 |
| （２）Class and number of shares to be disposed of |
90,000 shares of common stock of the Company |
| （３）Disposal price | 3,234 yen per share |
| （４）Total value of share to be disposed of |
291,060,000 yen |
| （５）Allottees and number thereof; number of disposed shares |
Members of the Board of Directors of the Company (excluding Outside Directors) 5 persons / 90,000 shares |